• Recall is isolated to powder formulas, including Similac®, Alimentum ® and EleCare®, manufactured at the Sturgis, Mich., plant
  • Recall does not include any metabolic deficiency nutrition formulas
  • No Abbott liquid formulas or other Abbott nutrition powders and brands are impacted
  • Parents or customers with impacted product should visit similacrecall.com or call +1-800-986-8540

ABBOTT PARK, Ill., Feb. 17, 2022 /PRNewswire/ — Abbott (NYSE: ABT) is initiating a proactive, voluntary recall of powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Mich., one of the company’s manufacturing facilities. The recall does not include any metabolic deficiency nutrition formulas.

Abbott is voluntarily recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility.

Additionally, as part of Abbott’s quality processes, we conduct routine testing for Cronobacter sakazakii and other pathogens in our manufacturing facilities. During testing in our Sturgis, Mich., facility, we found evidence of Cronobacter sakazakii in the plant in non-product contact areas. We found no evidence of Salmonella Newport. This investigation is ongoing.

Importantly, no distributed product has tested positive for the presence of either of these bacteria, and we continue to test. Abbott conducts extensive quality checks on each completed batch of infant formula, including microbiological analysis prior to release. All finished products are tested for Cronobacter sakazakii, Salmonella Newport and other pathogens and they must test negative before any product is released. Additionally, retained samples related to the three complaints for Cronobacter sakazakii tested negative for Cronobacter sakazakii. And the retained sample related to the complaint for Salmonella Newport tested negative for Salmonella Newport.

While Abbott’s testing of finished product detected no pathogens, we are taking action by recalling the powder formula manufactured in this facility with an expiration of April 1, 2022, or later. No Abbott liquid formulas, powder formulas, or nutrition products from other facilities are impacted by the recall.

Cronobacter sakazakii is commonly found in the environment and a variety of areas in the home. It can cause fever, poor feeding, excessive crying or low energy as well as other serious symptoms. It’s important to follow the instructions for proper preparation, handling and storage of powder formulas.

Read the full article >

Atracare Health Pediatrician Dr. Lewis is recommending that patients on one of the recalled Similac formulas switch to the equivalent Enfamil formulas as follows:
  • Similac Advance/Pro-Advance: Switch to Enfamil NeuroPro
  • Similac Sensitive: Switch to Enfamil Sensitive
  • Similac Total Comfort: Switch to Enfamil Gentlease
  • Similac Alimentum: Switch to Nutramigen

Contact Atracare Health with questions or inquiries related to this recall.

0 New comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News and Clinic Information

We are your partner in health. Stay up to date with latest news and information.

Awiqli Once-Weekly Insulin for Type 2 Diabetes

Awiqli, also known as insulin icodec, is a once-weekly basal insulin approved for adults with type 2 diabetes. It may help reduce the burden of daily insulin injections while supporting A1c reduction, but careful dosing and patient education are essential.

Read More

More Than 350 Lyme Disease Cases Reported in Delaware in 2025

More than 350 cases of Lyme disease, Delaware’s most common tick-borne disease, were reported in 2025, reinforcing why tick prevention matters across the state.

Read More

More Than 200 Alpha-Gal Syndrome Cases Reported in DE

More than 200 cases of alpha-gal syndrome have been reported in Delaware since it became reportable in 2024, making tick prevention more important for residents and visitors.

Read More